Arrowhead Pharmaceuticals
ARWR
#2176
Rank
NZ$14.70 B
Marketcap
NZ$106.35
Share price
-4.98%
Change (1 day)
164.97%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total debt

Total debt on the balance sheet as of June 2025 : NZ$0.61 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total debt is NZ$0.61 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Arrowhead Pharmaceuticals - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-09-30NZ$0.80 B318.83%
2023-09-30NZ$0.19 B32.75%
2022-09-30NZ$0.14 B290.72%
2021-09-30NZ$37.03 M16.05%
2020-09-30NZ$31.91 M
2019-09-30N/A-100%
2018-09-30NZ$3.51 M-0.36%
2017-09-30NZ$3.52 M-6.24%
2016-09-30NZ$3.75 M216.55%
2015-09-30NZ$1.18 M-9.34%
2014-09-30NZ$1.3 M-52.86%
2013-09-30NZ$2.77 M-5.64%
2012-09-30NZ$2.94 M272.29%
2011-09-30NZ$0.79 M16.02%
2010-09-30NZ$0.68 M-60.35%
2009-09-30NZ$1.71 M-24.7%
2008-09-30NZ$2.28 M
2002-09-30NZ$1.34 M-2.07%
2001-09-30NZ$1.37 M-0.87%
2000-09-30NZ$1.38 M26.95%
1999-09-30NZ$1.09 M-48.99%
1998-09-30NZ$2.13 M33.71%
1997-09-30NZ$1.6 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Alnylam Pharmaceuticals
ALNY
NZ$2.26 B 270.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.78 B 27.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
NZ$17.34 M-97.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.27 B 12,871.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ$1.27 B 107.91%๐Ÿ‡บ๐Ÿ‡ธ USA